Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas
In short
The company's updated financial outlook reflects continued international market interest in its vaccine products. Sustained overseas appetite for COVID-19 shots has enabled the drugmaker to lift its annual revenue targets. This updated guidance demonstrates that global demand remains a core driver of the firm's broader commercial strategy.
Key points
- International market interest is actively driving an increase in the firm's projected ear…: International market interest is actively driving an increase in the firm's projected earnings.
- Foreign orders for COVID-19 vaccines remain sufficiently resilient to alter annual compan…: Foreign orders for COVID-19 vaccines remain sufficiently resilient to alter annual company targets.
- Global demand outside domestic borders continues to underpin the company's updated revenu…: Global demand outside domestic borders continues to underpin the company's updated revenue outlook.